Table 7.
Risk prediction on PD-1 monoclonal antibody treatment-related adverse reactions in late-stage non-small cell lung cancer with KARS G12C mutation
| Parameter | coef | Odds ratio | B | beta | P Value |
|---|---|---|---|---|---|
| LCP1 Expression (mRNA) | 0.611 | 1.842 | 2.305 | 0.611 | 0.021 |
| ADPGK Expression (mRNA) | 0.936 | 2.549 | 3.022 | 0.936 | 0.003 |
| LCP1 Protein Level | 2.257 | 9.554 | 3.111 | 2.257 | 0.002 |
| ADPGK Protein Level | 2.308 | 10.058 | 2.364 | 2.308 | 0.018 |
Note: LCP1: Leukocyte-specific protein 1; ADPGK: adenosine diphosphate-dependent glucokinase; mRNA: Messenger Ribonucleic Acid.